Rigel Pharmaceuticals


Rigel Pharmaceuticals Photos

Rigel Building

+ Add Photo

Rigel Pharmaceuticals Reviews

6 Reviews
6 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
James M. Gower
4 Ratings

    Great for learning!

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Senior Research Associate in South San Francisco, CA
    Current Employee - Senior Research Associate in South San Francisco, CA

    I have been working at Rigel Pharmaceuticals full-time (more than 3 years)


    *Great training and education, especially if you're fresh off college
    *Competitive pay and healthcare benefits
    *Friendly colleagues
    *Inspiring CSO
    *High standards from managers, which is a good thing if you truly want to improve and learn


    *Many clinical trial failures, which can take a toll on your psychology
    *Expect to work long hours if you have project deadlines

    Advice to ManagementAdvice

    They try to keep you if they can (i.e. if they have money). Very inspiring and scientifically savvy people here. But a lot of times the drug industry relies on luck.

    Negative Outlook
    Approves of CEO

Rigel Pharmaceuticals Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Pharmaceuticals Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online. The process took 2 daysinterviewed at Rigel Pharmaceuticals in June 2010.

    Interview Details

    Very organized HR department.

    Interview Questions
    No Offer
    Neutral Experience
    Average Interview

Rigel Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.rigel.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (RIGL)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its research and development efforts on inflammatory/autoimmune, muscle, and metabolic diseases. Drugs in development include candidates for treating rheumatoid arthritis, psoriasis, muscle wasting, multiple sclerosis, and transplant rejection. Rigel prefers to collaborate with larger pharmaceutical companies in the development of its drug candidates. Rigel Pharmaceuticals went public through a $140 million IPO in 2011. The company intends to use the funds... More

Work at Rigel Pharmaceuticals? Share Your Experiences

Rigel Pharmaceuticals

Click to Rate